Sponsor
Andrew S. Biggs
Representative · R-AZ
Representative · R-AZ
The bill shifts prescription authority to states—potentially improving access in permissive states and aligning rules locally—while creating uneven access, legal complexity, and transition risks for providers and patients across state lines.
Patients in states that loosen prescription rules: gain easier access to medications that were previously federally prescription-only, improving treatment access for chronic-condition patients and those on Medicaid/Medicare.
State governments: receive authority to set which drugs require a prescription so they can tailor rules to local medical standards and policy priorities.
Women and health systems: retain a uniform federal enforcement focus limited to abortion drugs, maintaining a consistent federal stance on medication abortion enforcement.
Hospitals, telemedicine providers, and patients across states: face a patchwork of differing prescription definitions and access rules that will complicate prescribing, interstate telemedicine, and federal program administration.
Patients in states that keep strict prescription rules: will continue to face (or may face increased) barriers to accessing medications compared with residents of more permissive states, worsening geographic inequities in care.
Pharmacies and clinicians operating across state lines: will face legal uncertainty and added compliance costs as they navigate varied state prescription definitions and rules.
Based on analysis of 2 sections of legislative text.
Removes federal authority to require prescriptions for most drugs after six months, leaving prescription status primarily to state law while keeping federal control for abortion drugs.
Introduced January 3, 2025 by Andrew S. Biggs · Last progress January 3, 2025
Removes the FDA’s federal authority to require that most drugs be dispensed only by prescription, six months after enactment, and shifts responsibility for defining and enforcing prescription status to state law. The Secretary of Health and Human Services keeps federal prescription authority only for drugs intended to terminate a pregnancy. After the six-month delay, federal references to “prescribing,” “prescription,” and related terms will be read as references to the comparable state-law concept or state requirement, as determined by the responsible federal official(s). No new funding or programs are created.